<DOC>
	<DOCNO>NCT00436228</DOCNO>
	<brief_summary>SB-742510 semi-synthetic pleuromutilin antibiotic develop treatment respiratory infection . The purpose study estimate bioavailability four different formulation evaluate safety four formulation</brief_summary>
	<brief_title>To Study And Compare Bioavailability And Safety Of Four Different Formulations Of The Study Drug</brief_title>
	<detailed_description />
	<criteria>Healthy determine responsible physician , base medical evaluation perform screen . Healthy adults 18 60 year age , inclusive . Body weight proportional height . Capable give write informed consent . Female subject must nonchildbearing potential . QTc le 450 msec screen Any clinically relevant abnormality identify screen history physical 12lead surface electrocardiogram screen predose . The subject positive prestudy alcohol/urine drug screen . History regular use tobacco , nicotinecontaining product . A positive prestudy HIV antibody , Hepatitis B surface antigen ( HBsAg ) Hepatitis C antibody result within 3 month screen . Use certain prescription nonprescription drug , include vitamin , herbal dietary supplement . An unwillingness comply lifestyle and/or dietary restriction .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>healthy volunteer ,</keyword>
	<keyword>Bioavailability ,</keyword>
	<keyword>safety</keyword>
	<keyword>Phase I ,</keyword>
</DOC>